Pharmedium Healthcare Holdings Inc. filed for their initial public offering late Monday with an eye on raising up to $100 million. The company provides hospitals with compounded sterile preparations, or formulations of drug combinations that are not otherwise commercially available. Credit Suisse, J.P. Morgan, Morgan Stanley, Bank of America Merrill Lynch, and Goldman Sachs were listed as underwriters. The company plans to trade on the New York Stock Exchange udner the symbol "PMHC." Pharmedium posted sales of $209.5 million for the six months ending June 30.
Copyright © 2015 MarketWatch, Inc.